Legato Capital Management LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1442641
San Francisco, CA
Position in BCRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$828,335
+$641,533 QoQ
Shares Held
87,010
+263.3% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $3,175,895 across 3 Drug Manufacturers - Specialty & Generic names.
All Filings in BCRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $828,335 | 87,010 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $186,802 | 23,949 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $165,287 | 21,777 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $195,121 | 21,777 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $165,915 | 22,122 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $177,419 | 23,593 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $179,306 | 23,593 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $145,804 | 23,593 | Shares | Other | 2024-07-26 | |
| 2024-03-31 | $117,983 | 23,225 | Shares | Other | 2024-04-15 | |
| 2023-12-31 | $139,117 | 23,225 | Shares | Other | 2024-01-16 | |
| 2023-09-30 | $164,433 | 23,225 | Shares | Other | 2023-10-12 | |
| No filing history on record for this holder in this stock. | ||||||